Anaphylactoid reaction to high-dose methotrexate and successful desensitization

Pediatric Blood and Cancer

Volumn 55, Issue 3, 2010, Pages 557-559

  Oulego Erroz, Ignacio ^a   Maneiro Freire, Mercedes ^a   Bouzón Alejandro, Marta ^a   Vázquez Donsión, Manuel ^a   Couselo, José Miguel ^a  

^a University Hospital of Santiago de Compostela   (Spain)

Author keywords

Anaphylactoid reaction; Desensitization; High dose methotrexate

Indexed keywords

DEXAMETHASONE; DEXCHLORPHENIRAMINE; FOLINIC ACID; HYDROCORTISONE; METHOTREXATE; ONDANSETRON; RANITIDINE; ANTINEOPLASTIC ANTIMETABOLITE;

ALKALINIZATION; ANAPHYLAXIS; ARTICLE; CASE REPORT; CHILD; CLINICAL PROTOCOL; DESENSITIZATION; DRUG EFFICACY; DRUG EXPOSURE; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HIGH RISK PATIENT; HUMAN; OSTEOSARCOMA; PREMEDICATION; PRIORITY JOURNAL; PULSE OXIMETRY; RETREATMENT; SCHOOL CHILD; VOMITING; BONE TUMOR; METHODOLOGY; TIBIA;

ANAPHYLAXIS; ANTIMETABOLITES, ANTINEOPLASTIC; BONE NEOPLASMS; CHILD; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HUMANS; METHOTREXATE; OSTEOSARCOMA; TIBIA;

EID: 77955502669     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22616     Document Type: Article

References (19)

1. Bourchireb K, Dodille A, Ponvert C, et al. Management and successful desensitization in methotrexate-induced anaphylaxis. Pediatr Blood Cancer 2009;52:295-297.
2. Caldeira T, Costa V, Silva I, et al. Anaphylactoid reaction to high-dose methotrexate and re-administration after a successful desensitization. Pediatr Hematol Oncol 2008;25:131-134. (Pubitemid 351431229)
3. Elkiran ET, Altundag K, Aksoy S, et al. Systemic anaphylactic reaction following intrathecal administration of methotrexate in adult patient with primary central nervous system lymphoma. Am J Hematol 2004;75:265. (Pubitemid 38451115)
4. Al-Lamki Z, Thomas E, el-Banna N, et al. Acute urticaria and hepatitis complicating high-dose methotrexate therapy. Med Pediatr Oncol 1995;24:137-140.
5. Lobelle C, Lopez Rivas M, Barreiro J, et al. Anaphylactic reaction to high-dose methotrexate. Pediatr Hematol Oncol 1995;12:213-214.
6. Devecioglu O, Biner B, Karabocuoglu M, et al. Systemic near-fatal anaphylactic reaction after intrathecal methotrexate administration. Med Pediatr Oncol 2000;34:151-152. (Pubitemid 30090485)
7. Kohli A, Ferencz TM, Calderon JG. Readministration of high-dose methotrexate in a patient with suspected immediate hypersensitivity and T-cell acute lymphoblastic lymphoma. Allergy Asthma Proc 2004;25:249-252. (Pubitemid 39236977)
8. Straka M, Zeringue E, Goldman M. A rare drug reaction to methotrexate after treatment for ectopic pregnancy. Obstet Gynecol 2004;103:1047-1048.
9. MacGinnitie AJ, Walensky LD, Turvey SE, et al. Management of an anaphylactoid reaction to methotrexate with a stepwise graded challenge. Pediatr Allergy Immunol 2003;14:409-411.
10. Alkins SA, Byrd JC, Morgan SK, et al. Anaphylactoid reactions to methotrexate. Cancer 1996;77:2123-2126.
11. Lluch-Bernal M, Cuesta-Herranz J, De las Heras M, et al. Anaphylactic reaction to methotrexate. Allergy 1997;52:1150-1151.
12. Postovsky S, Elhasid R, Ben-Barak A, et al. Allergic reaction to high-dose methotrexate. Med Pediatr Oncol 2000;35:131-132.
13. Davis KA, Williams P, Walker JC. Successful desensitization to high-dose methotrexate after systemic anaphylaxis. Ann Allergy Asthma Immunol 2003;90:87-89. (Pubitemid 36553821)
14. Von Stackelberg A, Hartmann R, Bührer C, et al. High-dose compared with intermediate-dose methoterxate in children with a first relapse of acute lymphoblastic leukemia. Blood 2008;111:2573-2580.
15. Woessmann W, Seidemann K, Mann G, et al. The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: A report of the BFM group study NHL-BFM95. Blood 2005;105:948-958.
16. Keefe DA, Capizzi RL, Rudnick SA. Methotrexate cytotoxicity for l5178y/asn- lymphoblasts: Relationship of dose and duration of exposure to tumor cell viability. Cancer Res 1982;42:1641-1645.
17. Bacci G, Ferrari S, Delepine N, et al. Predictive factors of histologic response to primary chemotherapy in osteosarcoma of the extremity: Study of 272 patients preoperatively treated with high-dose methotrexate, doxorubicin, and cisplatin. J Clin Oncol 1998;16:658-663.
18. Bacci G, Ferrari S, Picci P, et al. Methotrexate serum concentration and histologic response to multiagent primary chemotherapy for osteosarcoma of the limbs. J Chemother 1996;8:472-478. (Pubitemid 27022552)
19. Crews KR, Liu T, Rodríguez-Galindo C, et al. High dose methotrexate pharmacokinetics and outcome of children and young adults with osteosarcoma. Cancer 2004;100:1724-1733. (Pubitemid 38456352)